PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis.

Kunwor, Ranju; Silver, Daniel P; Abu-Khalaf, Maysa

Kunwor, Ranju; Silver, Daniel P; Abu-Khalaf, Maysa.

Affiliation

Kunwor R; Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia, PA, USA.
Silver DP; Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia, PA, USA.
Abu-Khalaf M; Departments of Medical Oncology and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Hematol Oncol Stem Cell Ther ; 16(3): 186-196, 2023 Apr 04.

Article in En | MEDLINE | ID: mdl-37023220

Subject(s)

Breast Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Female; Humans; BRCA1 Protein/genetics; Breast Neoplasms/drug therapy; Breast Neoplasms/genetics; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use; Temozolomide/therapeutic use; BRCA2 Protein/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Poly(ADP-ribose) Polymerase Inhibitors Type of study: Clinical_trials / Systematic_reviews Limits: Female / Humans Language: En Journal: Hematol Oncol Stem Cell Ther Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google